(19)
(11) EP 4 798 969 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24809559.8

(22) Date of filing: 28.10.2024
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
G01N 33/483(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 3/00; G01N 33/4833; G01N 2203/0069; G01N 2800/52; G01Q 60/366; G01N 33/57557
(86) International application number:
PCT/EP2024/080424
(87) International publication number:
WO 2025/093480 (08.05.2025 Gazette 2025/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 26.10.2023 EP 23206259

(71) Applicant: Artidis AG
4057 Basel (CH)

(72) Inventors:
  • PLODINEC, Marija
    4057 Basel (CH)
  • NIZZERO, Sara
    4057 Basel (CH)
  • LOPARIC, Marko
    4057 Basel (CH)
  • OERTLE, Philipp
    4057 Basel (CH)
  • SRIVASTAVA, Gitika
    4057 Basel (CH)

(74) Representative: Schulz Junghans Patentanwälte PartGmbB 
Großbeerenstraße 71
10963 Berlin
10963 Berlin (DE)

   


(54) TISSUE NANOMECHANICAL SIGNATURE PREDICTS IMMUNOTHERAPY RESPONSE